EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacification

被引：0
|
作者：
C. Wertheimer
R. Liegl
M. Kernt
W. Mayer
D. Docheva
A. Kampik
K. H. Eibl-Lindner
机构：
[1] Ludwig-Maximilians-University,Department of Ophthalmology
[2] Ludwig-Maximilians-University,Experimental Surgery and Regenerative Medicine, Department of Surgery
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2013年 / 251卷
关键词：
Posterior capsule opacification; Cataract surgery; erlotinib; Tyrosine kinase inhibitor; Epidermal growth factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1529 / 1540
页数：11
相关论文
共 12 条
  • [1] EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacification
    Wertheimer, C.
    Liegl, R.
    Kernt, M.
    Mayer, W.
    Docheva, D.
    Kampik, A.
    Eibl-Lindner, K. H.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (06) : 1529 - 1540
  • [2] The intraocular lens as a drug delivery device for an epidermal growth factor-Receptor inhibitor for prophylaxis of posterior capsule opacification
    Wertheimer, Christian
    Kueres, Alexander
    Siedlecki, Jakob
    Braun, Christian
    Kassumeh, Stefan
    Wolf, Armin
    Mayer, Wolfgang
    Priglinger, Claudia
    Priglinger, Siegfried
    Eibl-Lindner, Kirsten
    ACTA OPHTHALMOLOGICA, 2018, 96 (07) : E874 - E882
  • [3] Development of a drug-eluting intraocular lens to deliver epidermal growth factor receptor inhibitor gefitinib for posterior capsule opacification prophylaxis
    Kassumeh, Stefan
    Kueres, Alexander
    Hillenmayer, Anna
    von Studnitz, Annabel
    Elhardt, Carolin
    Ohlmann, Andreas
    Priglinger, Siegfried G.
    Wertheimer, Christian M.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (02) : 436 - 444
  • [4] Promising Pharmacological Interventions for Posterior Capsule Opacification: A Review
    Liu, Yuxuan
    Dong, Xiaoming
    Wu, Bin
    Cheng, Zhigang
    Zhang, Jinsong
    Wang, Jing
    GLOBAL CHALLENGES, 2024, 8 (12)
  • [5] Pharmacological attempts to reduce posterior capsule opacification after cataract surgery - a review
    Walker, Thomas D.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2008, 36 (09) : 883 - 890
  • [6] EGFR inhibitor Gefitinib attenuates posterior capsule opacification in vitro and in the ex vivo human capsular bag model
    Wertheimer, Christian
    Siedlecki, Jakob
    Kook, Daniel
    Mayer, Wolfgang J.
    Wolf, Armin
    Klingenstein, Annemarie
    Kampik, Anselm
    Eibl-Lindner, Kirsten
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 253 (03) : 409 - 417
  • [7] Therapeutic potential of a dual mTORC1/2 inhibitor for the prevention of posterior capsule opacification: An in vitro study
    Feng, Hao
    Yang, Zhibo
    Bai, Xue
    Yang, Meirong
    Fang, Yuan
    Zhang, Xiaonan
    Guo, Qiqiang
    Ning, Hong
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (04) : 2099 - 2107
  • [8] EGFR inhibitor Gefitinib attenuates posterior capsule opacification in vitro and in the ex vivo human capsular bag model
    Christian Wertheimer
    Jakob Siedlecki
    Daniel Kook
    Wolfgang J. Mayer
    Armin Wolf
    Annemarie Klingenstein
    Anselm Kampik
    Kirsten Eibl-Lindner
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2015, 253 : 409 - 417
  • [9] The Intraocular Lens as a Drug Delivery Device: In Vitro Screening of Pharmacologic Substances for the Prophylaxis of Posterior Capsule Opacification
    Wertheimer, Christian
    Kassumeh, Stefan
    Piravej, Nick P.
    Nilmayer, Olga
    Braun, Christian
    Priglinger, Claudia
    Luft, Nikolaus
    Wolf, Armin
    Mayer, Wolfgang J.
    Priglinger, Siegfried G.
    Eibl-Lindner, Kirsten H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (14) : 6408 - 6418
  • [10] Clinical Translation of Long-Acting Drug Delivery Systems for Posterior Capsule Opacification Prophylaxis
    Li, Xinyang
    Liang, Chen
    Guo, Yexuan
    Su, Jing
    Chen, Xi
    Macgregor Jr, Robert B.
    Zhang, Rui Xue
    Yan, Hong
    PHARMACEUTICS, 2023, 15 (04)
12